Natural Product-Based Therapeutic Potential of Fagonia arabica: Phytochemical Characterization and Biological Activities of Leaf and Seed Extracts
Pharmaceuticals · 23.08.2026 · 19 (9) · 1330
DOI: 10.3390/ph19091330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 23.08.2026. Verfasst von Ibrahim M Aziz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Background/Objectives: The increasing global prevalence of chronic diseases has intensified the search for potential natural therapeutic agents. Fagonia arabica is a medicinal plant widely used in traditional medicine; however, comparative information on the phytochemical composition and biological activities of its leaves and seeds remains limited. To the best of our knowledge, this study represents the first comparative investigation of the phytochemical profiles and bioactivities of methanolic leaf (FALE) and seed (FASE) extracts of F. arabica collected from Riyadh, Saudi Arabia.
Methods
Methanolic extracts were analyzed by gas chromatography–mass spectrometry (GC–MS), and their total phenolic content (TPC), total flavonoid content (TFC), antioxidant, antimicrobial, anticancer, and antidiabetic activities were evaluated using standard in vitro assays.
Results
GC–MS analysis identified 60 and 68 compounds in FALE and FASE, respectively, with (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid, hexadecanoic acid, dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, and (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-Hexamethyl-1-(prop-1-en-2-yl)-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol as major constituents. FASE exhibited higher TPC and TFC values (104.13 mg GAE/g and 62.16 mg QE/g, respectively) than FALE. Both extracts demonstrated antioxidant activity, with FASE showing greater potency against DPPH and ABTS radicals (IC50 = 63.3 and 42.4 μg/mL, respectively). FASE also displayed broad-spectrum antimicrobial activity, particularly against Staphylococcus aureus (MIC = 7.81 μg/mL). Furthermore, FASE exhibited stronger concentration-dependent cytotoxicity against MCF-7 and HepG2 cells, with IC50 values of 106.8 and 89.5 μg/mL, respectively, compared with 112.5 and 103.1 μg/mL for FALE. Apoptosis induction in MCF-7 and HepG2 cells was associated with upregulation of caspase-3, caspase-8, caspase-9, and Bax, alongside downregulation of Bcl-2 and Bcl-xL. In addition, FASE exhibited potent α-amylase and α-glucosidase inhibitory activities (IC50 = 61.62 and 67.38 μg/mL, respectively), comparable to acarbose.
Conclusions
These findings highlight F. arabica seed extract as a promising source of multifunctional bioactive compounds with potential pharmaceutical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Ibrahim M Aziz, Reem M Aljowaie
Förderung
- King Saud University
Zitieren
APA
Aziz, I. M., Alshalan, R. M., & Aljowaie, R. M. (2026). Natural Product-Based Therapeutic Potential of Fagonia arabica: Phytochemical Characterization and Biological Activities of Leaf and Seed Extracts. Pharmaceuticals, 19(9), 1330. https://doi.org/10.3390/ph19091330
Vancouver
Aziz IM, Alshalan RM, Aljowaie RM. Natural Product-Based Therapeutic Potential of Fagonia arabica: Phytochemical Characterization and Biological Activities of Leaf and Seed Extracts. Pharmaceuticals. 2026;19(9):1330. doi:10.3390/ph19091330
BibTeX
@article{Aziz2026,
author = {Aziz, Ibrahim M and Alshalan, Rawan M and Aljowaie, Reem M},
title = {Natural Product-Based Therapeutic Potential of Fagonia arabica: Phytochemical Characterization and Biological Activities of Leaf and Seed Extracts},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {9},
pages = {1330},
doi = {10.3390/ph19091330}
}
EUVIMED